~~<i id='D4A90D2E62'><strike id='D4A90D2E62'><tt id='D4A90D2E62'><pre id='D4A90D2E62'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：Wikipedia 2025-09-30 00:51:24 - browse：89

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Orangutan used medicinal plant to treat wound, first time ever seen

knowledge

focus

knowledge

focus

hotspot

6:57FileimageoftheTitansubmersiblepriortocommencediving.OceanGateMultinationalsearchandrescueefforts

WSS

Getting Alzheimer's drug Leqembi to patients can be a challenge

Leon Gautier, last member of French D

Leon Gautier, last member of French D

EU climate chief is concerned over the expansion of the coal industry in China

Medical bills so high, Medicare adding extra digits to claim forms

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

entertainment

Wikipedia

knowledge

Tori Bowie and the unacceptable rates of Black maternal death

Greece's new parliament sworn in following conservative party's election victory

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Moonlake's readout produced a cash windfall. Risks remain

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Apple is now the first public company to be valued at $3 trillion

Melinda French Gates resigns from Gates Foundation

Medicare details structure of new drug price negotiation program

Cholera vaccine supply gets boost as demand surges globally

focus

MultiPlan and major insurers sued for alleged medical price

Melinda French Gates resigns from Gates Foundation

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Elon Musk announces 'temporary limits' for reading Twitter posts

Cell therapy fails to slow type 1 diabetes, but safety is established

Bird flu outbreak in cows is latest avian flu curveball

knowledge

focus

focus

hotspot